Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 10mg | $120.00 | $12.00/mg | In stock | Jul 8 |
| vial | 30mg | $265.00 | $8.83/mg | In stock | Jul 8 |
| vial | 60mg | $450.00 | $7.50/mg | In stock | Jul 8 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| 4032026RT | May 2026 | 99.5% | Janoshik Analytical | — | Confirmed | View |
Does Prime Peptides sell Retatrutide?
Yes — Prime Peptides currently lists Retatrutide in 3 variants starting at $450.00 ($7.50/mg).
Is Prime Peptides's Retatrutide third-party tested?
Yes — Disclosed Labs has indexed 6 Certificates of Analysis for Prime Peptides's Retatrutide, with the most recent showing 99.5% purity. Prime Peptides holds an overall trust grade of C (72/100) across all 53 COAs on file.
What is Prime Peptides's trust grade for Retatrutide?
Prime Peptides has an overall Disclosed Labs trust grade of C (72/100), computed from 53 COAs across all peptides. The most recent Retatrutide COA was issued by Janoshik Analytical.
Where is the cheapest Retatrutide?
As of the latest data, Peptide Supply Co. offers Retatrutide at $2.40/mg — compare with Prime Peptides's listing at $7.50/mg. See the full Retatrutide price comparison.
| 3302026RT | May 2026 | 99.2% | Janoshik Analytical | — | Confirmed | View |
| 3202026RT | Apr 2026 | 99.8% | Bioviridian | Endotoxin | Confirmed | View |
| 3172026RT | Apr 2026 | 99.8% | Bioviridian | — | Confirmed | View |
| 1102026RT | Mar 2026 | 99.8% | Janoshik Analytical | — | Confirmed | View |
| 10172025RT | Feb 2026 | 99.4% | Janoshik Analytical | — | Confirmed | View |
Disclosed Labs